It was recently shown in this laboratory (1) that in idiopathic hyperlipemia the elimination of lipids from the blood stream following an intravenous infusion of a fat emulsion is considerably delayed, indicating a defect of the lipemiaclearing mechanism in these patients.
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It was then found that the clearing activity present in the serum of normal human subjects who have received heparin was inhibited by the serum of patients with primary or secondary hyperlipemia (2) . It was suggested that this inhibition of clearing was the cause of the hyperlipemia.
Seifter and Baeder (3) have shown that an inhibitor of lipemia clearing is present in the serum of rats with experimental nephrosis and those receiving cortisone. In addition they demonstrated the presence of an inhibitor of lipemia clearing in the serum of normal rats, although its concentration was much lower than in rats receiving cortisone. Crum, I lein and Lever (4) have separated dialyzable and nondialyzable inhibitors of lipemia clearing from normal bovine serum (5). Hollett and Meng (6) have recently described the presence of an inhibitor of lipemia clearing in normal human blood.
MATERIALS AND METHODS
The sera of 5 patients with idiopathic hyperlipeniia (hyperlipemic sera) and of 5 normal human subjects (normal sera) were studied. The patients as well as control subjects had been fasting for 12 hours preceding the removal of blood for these tests. Clearing factor containing serum (active serum) was obtained from normal human subjects 15 minutes after they had received heparint intravenously in a dosage of .75 mg./kg. of body weight. The serum was either used or frozen immediately after separation, since it had been noted that the clearing activity of post-heparin serum decreased quite rapidly at room temperature. On incubation at 38° C. the loss of clearing activity was even greater and amounted to 00 per cent over an 8 hour period.
The following methods were used for the experiments reported here: 1. In order to compare quantitatively the effects of normal and of hyperlipemic sera on the clearing activity of active serum, varying amounts of either normal serum or hyperlipemic serum were mixed with active serum, the final volume being kept constant at 1.2 cc. Then 0.3 cc. of a standard fat emulsion was added to the mixtures and the optical den-sity changes were determined spectrophotometrically at intervals of 10 minutes as described by Grossman (7).
2. In order to determine whether the inhibitory activity was associated with the serum lipids, the sera of patients with idiopathic hyperlipemia obtained both before and after the intravenous administration of 100 mg. of heparin were centrifuged at 32,000 g for 30 minutes at 4° C. The sera of normal control subjects in a state of alimentary lipemia (induced by the ingestion of 200 cc. of 10 per cent cream 4 hours prior to drawing the blood sample) were similarly centrifuged. The supernatant lipid fraction was separated from the clear infranatant Fraction (F-Il). The supernatant lipid fraction was diluted with 4 volumes of normal serum (F-I). Aliquots of 0.6 cc. F-I or F-Il were added to 0.6 cc. of active serum and 0.3 cc. of standard fat emulsion were added to the mixture. The optical density changes were determined as described above (7). RESULTS 1. Reduction of clearing activity in active serum by normal and hyperlipemic sera ( Fig. 1) . Gradual dilution of active serum with normal serum did not result in any reduction of clearing activity until the mixture consisted of equal parts of active serum and normal serum. Almost 50 per cent of the original clearing activity was still present when the mixture contained only 1 part of active serum to 9 parts of normal serum. On further dilution with normal serum the rate of clearing decreased rapidly.
The rate of reduction of clearing activity was considerably greater on dilution with hyperlipemic serum than with normal serum. Addition of 1 part of 400 FIG. 1. Changes in clearing activity (i.e., decrease in optical density,-OD) in serum containing clearing activity on gradual dilution with normal serum and with serum of patients with idiopathic hyperlipemia, respectively. On dilution with normal serum no significant reduction of clearing activity occurs at first. After dilution to less than 10 per cent a rapid decrease in clearing activity takes place. Dilution with hyperlipemic serum, on the other hand, leads to initial rapid decrease in clearing activity. (Table I ). The lipid layer obtained by high speed centrifugation of the fasting serum of 4 patients with idiopathic hyperlipemia, contained all the inhibitory activity, while the clear infranatant layer contained none. When the serum of these patients was tested after they had received heparin intravenously, it was found that the inhibition had shifted to the infranatant layer and that the supranatant layer contained the heparin-induced clearing activity. Neither the lipid fraction nor the infranatant fraction of the serum of normal subjects with alimentary hyperlipemia had any inhibitory effect on the clearing activity.
DISCUSSION
The clearing activity of active serum on gradual dilution with normal serum was not significantly affected until a 10-fold dilution was reached. Thus there is no stoichiometric relation between the diluent (normal serum) and the agent producing clearing. This suggests that lipemia-clearing is due to an enzymatic activity in the serum. Other explanations appear unlikely since the concentration of essential factors of the clearing system other than heparin-induced clearing factor have not been altered by the addition of normal serum. The lipemia-clearing activity in the serum may be analogous to the lipoprotein lipase of tissues (tissue clearing factor) previously described by Korn (8) . The decrease of clearing activity upon gradual dilution with hyperlipemic serum was rapid, indicating that hyperlipemic serum exerts a strongly inhibitory effect on lipemia-clearing.
It should be pointed out that according to the findings of Hollett and Meng (6) some inhibitory activity is present in normal human serum. The data presented here, however, indicate that the concentration of inhibitor in hyperlipemic serum greatly exceeds that present in normal serum.
The observation that in hyperlipemic serum the inhibition of clearing activity is present in the supernatant lipid fraction before the intravenous administration of heparin while afterwards the inhibition is present in the infranatant fraction and clearing activity in the supranatant fraction, suggests that the heparininduced clearing factor displaces an inhibitor from the supernatant lipid fraction.
This may be due to the fact that the heparin-induced clearing factor becomes associated with the serum lipids. Evidence for this assumption is our recent observation that on continuous paper electrophoresis of active serum, over 80 per cent of the clearing activity is present in the alpha-and beta-lipoprotein fractions (9).
SUMMARY AND CONCLUSIONS 1. Gradual dilution of clearing activity containing serum (in vivo heparinized "active serum") with normal fasting serum caused no significant reduction of clearing activity until the concentrations of the active serum was reduced to 50 per cent. After dilution to less than 10 per cent clearing activity decreased rapidly. On the other hand, gradual dilution of active serum with serum from patients with idiopathic hyperlipemia resulted in a rapid initial decrease in clearing activity.
2. The slow initial decrease in clearing activity on addition of normal serum suggests that lipemia clearing in active serum is due to an enzymatic activity.
The rapid decrease in clearing activity on addition of serum from patients with idiopathic hyperlipemia indicates that such serum strongly inhibits lipemia clearing.
3. The inhibitory activity present in the serum of patients with idiopathic hyperlipemia was localized in the supernatant lipid fraction after centrifugation of the serum in the fasting state. After intravenous administration of heparin the inhibitory activity was located in the clear infranatant fraction.
4. The shift in the localization of the inhibition after the administration of heparin occurred at the same time as the heparin-induced clearing factor became associated with the supernatant lipid fraction. It is possible, therefore, that the heparin-induced clearing factor displaces the inhibitor from the serum lipids of the supernatant layer.
